Evotec and novo nordisk enter into technology development partnership to support next-generation cell therapies

Novo nordisk will provide funding for technology development activities at evotec to support clinical and commercial manufacturing of stem cell-based therapies hamburg, germany / accesswire / september 26, 2024 / evotec se (frankfurt stock exchange:evt, sdax/tecdax, isin: de0005664809; nasdaq:evo) announced today that evotec has entered a technology development partnership with novo nordisk in cell therapy. both evotec and novo nordisk have significant expertise and a strategic focus to support stem cell-based therapies.
NVO Ratings Summary
NVO Quant Ranking